EWM
AMED

Endurance Wealth Management’s Amedisys AMED Stock Holding History

Endurance Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-547
Closed -$82K – 626
2021
Q3 		$82K Hold
547
– – 0.01% 303
2021
Q2 		$133K Hold
547
– – 0.01% 258
2021
Q1 		$145K Buy
547
+512
+1,463% +$144K 0.02% 245
2020
Q4 		$10K Hold
35
– – ﹤0.01% 491
2020
Q3 		$8K Buy
+35
New +$7.96K ﹤0.01% 490

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Endurance Wealth Management's AMED Position: Q4 2021 in Review

Endurance Wealth Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 547 shares — an estimated $82K sold.

Endurance Wealth Management first reported a position in AMED in Q3 2020 and held it in 5 quarters. The position peaked at $145K in Q1 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Endurance Wealth Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Endurance Wealth Management sold 547 Amedisys shares in Q4 2021, an estimated $82K.
  • Endurance Wealth Management first reported a position in Amedisys in Q3 2020 and held it in 5 quarters.
  • Endurance Wealth Management's Amedisys position peaked at $145K in Q1 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Endurance Wealth Management's 13F filing for Q4 2021, filed 19 Jan 2022.